Ceva’s 20 Billion Device Milestone Paves the Way for a New Era in Smart Edge Innovation
Achievement underscores Ceva’s technology leadership and deep industry partnerships for more than two decades, amid accelerating demand for ubiquitous edge... Read more.
Diebold Nixdorf Reports Strong Second Quarter Financial Results
Company Reaffirms Full-Year Outlook, Trending Toward the Higher End of the Range Strong First-Half Order Entry Supports Second-Half Revenue Outlook Delivers Third... Read more.
e123 Launches “Insuring Growth” Podcast to Enable Health Insurance Leaders to Drive Profitable Revenue Growth Amidst Trump Administration Policy Changes
LAGUNA HILLS, Calif., Aug. 6, 2025 /PRNewswire/ — e123, the leading health insurance distribution management system, announces the launch of its new podcast,... Read more.
PlusAI and Goodyear Collaborate to Enhance the Safety and Efficiency Features of Autonomous Trucks
SANTA CLARA, Calif., Aug. 6, 2025 /PRNewswire/ — PlusAI, an artificial intelligence company commercializing AI-based virtual driver software for factory-built... Read more.
PTC Will Participate in Upcoming Investor Conferences
BOSTON, Aug. 6, 2025 /PRNewswire/ — PTC (NASDAQ: PTC) today announced that it will participate in the following conferences. What: Oppenheimer 28th Annual... Read more.
Stavtar Solutions Secures $55 Million from Elephant to Accelerate Growth and Scale Operations
NEW YORK, Aug. 6, 2025 /PRNewswire/ — Stavtar Solutions, a leading provider of business spend management and expense allocation SaaS for complex businesses... Read more.
Hippo Reports Second Quarter 2025 Financial Results
SAN JOSE, Calif., Aug. 6, 2025 /PRNewswire/ — Hippo (NYSE: HIPO), the tech-enabled insurance group proactively protecting homeowners and supporting program... Read more.
Capital Square Acquires Active Adult Build-For-Rent Community Near San Antonio, Texas, for New DST Offering
SAN ANTONIO, Aug. 6, 2025 /PRNewswire/ — Capital Square, one of the nation’s leading sponsors of tax-advantaged real estate investments and an active... Read more.
Compugen Reports Second Quarter 2025 Results
First patient dosed in MAIA-ovarian platform trial of COM701 maintenance therapy in patients with platinum sensitive ovarian cancer in July 2025 Pooled analysis... Read more.
Q32 Bio Reports Second Quarter 2025 Financial Results and Provides Corporate Update
— Dosing of patients in Part A open-label extension (OLE) and Part B of SIGNAL-AA ongoing; SIGNAL-AA Part B topline data readout on-track for 1H’26 —... Read more.